Which industry partner should I collaborate with? A scientists’ journey to implementing an innovative technology

2022-06-06T21:59:54+00:00June 3rd, 2022|Comments Off on Which industry partner should I collaborate with? A scientists’ journey to implementing an innovative technology

Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models

2021-11-03T20:19:50+00:00November 3rd, 2021|Comments Off on Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models

Efficient Electroporation of Neuronal Cells Using Synthetic Oligonucleotides: Identifying Duplex RNA and Antisense Oligonucleotide Activators of Human Frataxin Expression

2021-10-01T18:33:35+00:00September 30th, 2021|Comments Off on Efficient Electroporation of Neuronal Cells Using Synthetic Oligonucleotides: Identifying Duplex RNA and Antisense Oligonucleotide Activators of Human Frataxin Expression

Electroporation Enables Oligonucleotide Delivery to Regulate Gene Expression in Friedrich’s Ataxia Patient-Derived Cells

2021-09-30T17:04:35+00:00September 30th, 2021|Comments Off on Electroporation Enables Oligonucleotide Delivery to Regulate Gene Expression in Friedrich’s Ataxia Patient-Derived Cells

Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones

2021-10-01T18:35:14+00:00November 11th, 2020|Comments Off on Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones

CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering

2021-10-12T18:45:49+00:00May 16th, 2020|Comments Off on CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering
Go to Top